بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

/ بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

لايوجد

الموقع الشخصى

شريف امام عبدالله امام

الكلية الصيدلة - القسم الصيدلانيات

الدرجات العلمية

بكالوريوس فى الصيدلانيات, -جامعة الزقازيق [2008]
ماجستير فى الصيدلانيات, -جامعة الزقازيق [2012]

الحالة الوظيفية الحالية :

قائم بالعمل

التدرج الوظيفى الأكاديمى

معيد : 8/11/2008
مدرس مساعد : 20/12/2012
مدرس : 27/11/2018
أستاذ مساعد : 28/11/2023
استاذ مساعد لقب علمى : 28/11/2023

الأبحاث العلمية

1 - A Novel Strategy to Increase the Yield of Exosomes (Extracellular Vesicles) for an Expansion of Basic Research (1439).

2 - Doxorubicin Expands in Vivo Secretion of Circulating Exosome in Mice (1439).

3 - Liposome co-incubation with cancer cells secreted exosomes (extracellular vesicles) with different proteins expressions and different uptake pathways (1440).

4 - A Novel Strategy to Increase the Yield of Exosomes (Extracellular Vesicles) for an Expansion of Basic Research. (1439).

5 - Doxorubicin Expands in Vivo Secretion of Circulating Exosome in Mice. (1439).

6 - Liposome co-incubation with cancer cells secreted exosomes (extracellular vesicles) with different proteins expressions and different uptake pathways. (1440).

7 - Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues (1441).

8 - Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism (1442).

9 - Impact of Pre-Existing or Induced Anti-PEG IgM on the Pharmacokinetics of Peginterferon Alfa-2a (Pegasys) in Mice (1441).

10 - Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice (1441).

11 - Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice (1442).

12 - A mouse model for studying the effect of blood anti-PEG IgMs levels on the in vivo fate of PEGylated liposomes (1443).

13 - Electrospun Nanofibers Revisited: An Update on the Emerging Applications in Nanomedicine (1443).

14 - Incorporating Gangliosides into PEGylated Cationic Liposomes that Complexed DNA Attenuates Anti-PEG Antibody Production but Not Anti-DNA Antibody Production in Mice (1442).

15 - Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products (1444).

16 - Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route (1445).

17 - Treatment-induced and Pre-existing Anti-peg Antibodies: Prevalence, Clinical Implications, and Future Perspectives (1445).

18 - Myricetin-loaded SBA-15 silica nanoparticles for enhanced management of pyrexia, pain, and inflammation through modulation of MAPK/NF-κB and COX-2/PGE-2 pathways: Evidence from the biochemical, histological, and metabolomic analysis (1446).

المجالات البحثية

الصيدلانيات